The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Weight-loss injections could cut the risk of cancer by almost half, research suggests. Researchers analysed the health ...

Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut ...

A study has found that glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer anti-cancer benefits that extend beyond ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

Weight loss injections may have a powerful anti-cancer effect, new research suggests. Experts already know that losing weight ...

New research being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in ...

New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...

Weight loss jabs could “herald a whole new era of preventative cancer medicine” by slashing risk of obesity-related tumours, ...